The global infection control market is entering a phase of steady and strategic expansion, reflecting the growing importance of hygiene, safety, and regulatory compliance across healthcare and related industries. Valued at USD 57.31 billion in 2025, the market is projected to reach USD 77.67 billion by 2030, growing at a CAGR of 6.3%. This growth trajectory highlights how infection prevention has become a critical priority—not only for hospitals, but also for pharmaceutical companies, food processing industries, and medical device manufacturers.
At the heart of this growth is the rising prevalence of healthcare-associated infections (HAIs). These infections continue to pose serious risks to patient safety and significantly increase healthcare costs worldwide. As healthcare systems expand and the number of surgical procedures rises, the demand for effective sterilization and disinfection solutions has intensified. Hospitals and clinics are investing heavily in advanced infection control technologies to reduce complications and improve patient outcomes.
Download an Illustrative overview:
Technological advancements are also playing a central role in shaping the market. Modern sterilization equipment, including automated systems and advanced reprocessing technologies, is improving efficiency, consistency, and safety. Innovations such as E-beam sterilization and the renewed use of ethylene oxide (EtO) sterilization are expanding the range of solutions available to healthcare providers and manufacturers. These technologies are particularly valuable for sterilizing complex and heat-sensitive medical devices, where traditional methods may fall short.
Another key trend driving the market is the increasing emphasis on outsourcing infection control services. Pharmaceutical companies, hospitals, and medical device manufacturers are increasingly relying on specialized service providers for sterilization, instrument reprocessing, and facility hygiene management. This shift allows organizations to focus on core operations while ensuring compliance with stringent regulatory standards. As a result, the services segment is witnessing strong growth alongside product-based solutions.
The products and services segment itself is broad and dynamic. It includes sterilization and disinfection equipment, chemical disinfectants, consumables, and endoscope reprocessing systems. On the services side, offerings such as sterilization outsourcing and infection prevention consulting are gaining traction. The integration of innovative technologies into these solutions is enhancing their effectiveness, making infection control more reliable and scalable across different settings.
End users play a crucial role in driving demand within the infection control market. Hospitals, diagnostic laboratories, pharmaceutical companies, and food processing facilities are increasingly prioritizing hygiene and safety. Stricter regulations and growing awareness of infection risks are pushing organizations to adopt comprehensive infection control strategies. This shift is not only improving operational safety but also strengthening compliance and overall performance.
Regionally, Asia Pacific is emerging as a key growth engine for the market. The region is witnessing a rise in healthcare-associated infections, along with a growing number of surgical procedures. Rapid healthcare infrastructure development and increasing awareness of infection prevention are further accelerating demand for infection control solutions in countries across the region.
Despite these positive trends, the market faces several challenges. Concerns about the safety of reprocessed instruments and the potential health and environmental risks associated with chemical disinfectants remain significant. Additionally, the high cost of endoscopy reprocessing and limited reimbursement policies can hinder adoption, particularly in cost-sensitive markets.
At the same time, new opportunities are emerging. The expansion of pharmaceutical and medical device industries in developing countries is creating fresh demand for sterilization and infection control solutions. The growing adoption of advanced sterilization methods, such as E-beam technology, is also opening new avenues for innovation and growth.
However, the market must also navigate evolving challenges. The increasing complexity of modern medical devices makes sterilization more difficult, requiring continuous innovation in reprocessing technologies. Furthermore, the rise of alternative surface disinfection methods and the growing use of single-use medical devices could reduce reliance on traditional sterilization processes.
Leading companies such as STERIS, Reckitt Benckiser Group plc, Fortive, Sotera Health, and Solventum are actively shaping the competitive landscape. Through strategic partnerships, acquisitions, and continuous investment in research and development, these players are expanding their global footprint and strengthening their product portfolios.
In conclusion, the infection control market is on a stable growth path, driven by rising infection risks, technological advancements, and increasing regulatory pressure. While challenges persist, the combination of innovation, expanding global healthcare infrastructure, and growing awareness of hygiene standards ensures a promising future for the industry.
Buy an Infection Control Industry Report ( Pages PDF with Insightful Charts, Tables, and Figures):